Concomitant use may lower systemic exposures and reduce effectiveness. Closely monitor for reduced effectiveness; consider discontinuing VYVGART if long-term concomitant use is essential.
Source: NLP:efgartigimod alfa
Human Botulinum Neurotoxin A/B Immune Globulin Interactions
Brand names: Babybig
Human Immunoglobulin G · Bacterial Neurotoxin Neutralization
Route: Intravenous
Contraindications
4 CONTRAINDICATIONS As with other immunoglobulin preparations, BabyBIG should not be used in individuals with a prior history of severe reaction to other human immunoglobulin preparations. [1-4] Individuals with selective immunoglobulin A deficiency have the potential for developing antibodies to immunoglobulin A and could have anaphylactic reactions to the subsequent administration of blood products that contain immunoglobulin A. Prior history of severe reaction to other human immunoglobulin preparations ( 4 ) Selective immunoglobulin A deficiency with anti-IgA antibodies ( 4 )
13 interactions on record
Concomitant use may lower systemic exposures and reduce effectiveness. Closely monitor for reduced effectiveness.
Source: NLP:efgartigimod alfa and hyaluronidase (human recombinant)
Antibodies in BabyBIG may interfere with immune response to measles vaccine; vaccination should be deferred until 6 months after BabyBIG administration.
Source: NLP:human botulinum neurotoxin a/b immune globulin
Antibodies in BabyBIG may interfere with immune response to live measles vaccine. Vaccination should be deferred until 6 months after BabyBIG administration.
Source: NLP:human botulinum neurotoxin a/b immune globulin
Antibodies in BabyBIG may interfere with immune response to MMR vaccine; vaccination should be deferred until 6 months after BabyBIG administration.
Source: NLP:human botulinum neurotoxin a/b immune globulin
Antibodies in BabyBIG may interfere with immune response to live virus vaccine. Vaccination should be deferred until six months after BabyBIG administration.
Source: NLP:human botulinum neurotoxin a/b immune globulin
Antibodies in BabyBIG may interfere with immune response to live mumps vaccine. Vaccination should be deferred until 6 months after BabyBIG administration.
Source: NLP:human botulinum neurotoxin a/b immune globulin
Antibodies in BabyBIG may interfere with immune response to live mumps vaccine. Vaccination should be deferred until six months after BabyBIG administration.
Source: NLP:human botulinum neurotoxin a/b immune globulin
Antibodies in BabyBIG may interfere with immune response to live polio vaccine. Vaccination should be deferred until 6 months after BabyBIG administration.
Source: NLP:human botulinum neurotoxin a/b immune globulin
Antibodies in BabyBIG may interfere with immune response to live rubella vaccine. Vaccination should be deferred until 6 months after BabyBIG administration.
Source: NLP:human botulinum neurotoxin a/b immune globulin
Antibodies in BabyBIG may interfere with immune response to MMRV vaccine; vaccination should be deferred until 6 months after BabyBIG administration.
Source: NLP:human botulinum neurotoxin a/b immune globulin
Antibodies in BabyBIG may interfere with immune response to monovalent varicella vaccine; vaccination should be deferred until 6 months after BabyBIG administration.
Source: NLP:human botulinum neurotoxin a/b immune globulin
Antibodies in BabyBIG may interfere with immune response to live varicella vaccine. Vaccination should be deferred until 6 months after BabyBIG administration.
Source: NLP:human botulinum neurotoxin a/b immune globulin